NDC 10544-217
Glimepiride 2 mg tablet
On the label: Blenheim Pharmacal, Inc.. It's repackaged: Blenheim Pharmacal, Inc. rebottles it from Dr.Reddy's Laboratories Ltd.'s NDC 55111-321.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Dr. Reddy's Laboratories Limited | Medchal-Malkajgiri, India | Makes it and tests it | Problems found, fixed voluntarilyOct 27, 2023 · 8 inspections |
| Dr. Reddy's Laboratories Limited | Srikakulam, India | Makes it and tests it | Problems found, fixed voluntarilyMay 20, 2022 · 5 inspections |
Repackaging site
- Blenheim Pharmacal, Inc., North Blenheim, New York, United States · repackages it
Recalls
- Jan 18, 2024 · Class III · Dr. Reddy's Laboratories, Inc.
Misprint on tablet
Lots: Lot: T2303622; Exp. 06/2026 Lot: T2303626; Exp. 06/2026 Lot: T2303627; Exp. 06/2026 Lot: T2303628; Exp. 06/2026 Lot: T2303629; Exp. 06/2026 - Jan 18, 2024 · Class III · Dr. Reddy's Laboratories, Inc.
Misprint on tablet
Lots: Lot: T2303609; Exp. 06/2026 Lot: T2303610; Exp. 06/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Glimepiride: every company that makes it
- Form
- tablet
- Strength
- 2 mg
- Approval
- ANDA ANDA077091
- On the market since
- Oct 8, 2013
- Package NDCs
10544-217-30- Official label
- DailyMed (National Library of Medicine), updated Mar 4, 2015
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?